AAAAAA

   
Results: 1-15 |
Results: 15
MOLECULAR CORRELATES OF BCL-2-ENHANCED GROWTH FOLLOWING ANDROGEN-ABLATION IN PROSTATE CARCINOMA-CELLS IN-VIVO
Authors: BEHAM AW SARKISS M BRISBAY S TU SM VONESCHENBACH AC MCDONNELL TJ
Citation: Aw. Beham et al., MOLECULAR CORRELATES OF BCL-2-ENHANCED GROWTH FOLLOWING ANDROGEN-ABLATION IN PROSTATE CARCINOMA-CELLS IN-VIVO, INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 1(6), 1998, pp. 953-959
PHASE-I STUDY OF SURAMIN COMBINED WITH DOXORUBICIN IN THE TREATMENT OF ANDROGEN-INDEPENDENT PROSTATE-CANCER
Authors: TU SM PAGLIARO LC BANKS ME AMATO RJ MILLIKAN RE BUGAZIA NA MADDEN T NEWMAN RA LOGOTHETIS CJ
Citation: Sm. Tu et al., PHASE-I STUDY OF SURAMIN COMBINED WITH DOXORUBICIN IN THE TREATMENT OF ANDROGEN-INDEPENDENT PROSTATE-CANCER, Clinical cancer research, 4(5), 1998, pp. 1193-1201
PHASE-I STUDY OF SURAMIN COMBINED WITH DOXORUBICIN IN THE TREATMENT OF ANDROGEN-INDEPENDENT PROSTATE-CANCER
Authors: TU SM PAGLIARO LC BANKS ME AMATO RJ MILLIKAN RE BUGAZIA NA MADDEN T NEWMAN RA LOGOTHETIS CJ
Citation: Sm. Tu et al., PHASE-I STUDY OF SURAMIN COMBINED WITH DOXORUBICIN IN THE TREATMENT OF ANDROGEN-INDEPENDENT PROSTATE-CANCER, Clinical cancer research, 4(5), 1998, pp. 1193-1201
PRESENTATION, METHODS OF DIAGNOSIS AND THERAPY FOR PELVIC RECURRENCE FOLLOWING RADICAL CYSTECTOMY FOR TRANSITIONAL-CELL CARCINOMA OF THE BLADDER
Authors: WESTNEY OL PISTERS LL PETTAWAY CA TU SM POLLACK A DINNEY CPN
Citation: Ol. Westney et al., PRESENTATION, METHODS OF DIAGNOSIS AND THERAPY FOR PELVIC RECURRENCE FOLLOWING RADICAL CYSTECTOMY FOR TRANSITIONAL-CELL CARCINOMA OF THE BLADDER, The Journal of urology, 159(3), 1998, pp. 792-795
PHASE I-II STUDY OF GAMMA-INTERFERON AND 5-FLUOROURACIL FOR PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
Authors: DELIMA M AMATO RJ JACKSON A TU SM BANKS M FINN L ELLERHORST J
Citation: M. Delima et al., PHASE I-II STUDY OF GAMMA-INTERFERON AND 5-FLUOROURACIL FOR PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 12(6), 1997, pp. 365-370
PHASE-II TRIAL OF ALTERNATING WEEKLY CHEMOHORMONAL THERAPY FOR PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER
Authors: ELLERHORST JA TU SM AMATO RJ FINN L MILLIKAN RE PAGLIARO LC JACKSON A LOGOTHETIS CJ
Citation: Ja. Ellerhorst et al., PHASE-II TRIAL OF ALTERNATING WEEKLY CHEMOHORMONAL THERAPY FOR PATIENTS WITH ANDROGEN-INDEPENDENT PROSTATE-CANCER, Clinical cancer research, 3(12), 1997, pp. 2371-2376
ESTABLISHMENT OF 2 HUMAN PROSTATE-CANCER CELL-LINES DERIVED FROM A SINGLE BONE METASTASIS
Authors: NAVONE NM OLIVE M OZEN M DAVIS R TRONCOSO P TU SM JOHNSTON D POLLACK A PATHAK S VONESCHENBACH AC LOGOTHETIS CJ
Citation: Nm. Navone et al., ESTABLISHMENT OF 2 HUMAN PROSTATE-CANCER CELL-LINES DERIVED FROM A SINGLE BONE METASTASIS, Clinical cancer research, 3(12), 1997, pp. 2493-2500
BCL-2 EXPRESSION CONFERS ANDROGEN INDEPENDENCE IN ANDROGEN SENSITIVE PROSTATIC-CARCINOMA
Authors: WESTIN P LO P MARIN MC FERNANDEZ A SARKISS M TU SM BRISBAY SM VONESCHENBACH AC MCDONNELL TJ
Citation: P. Westin et al., BCL-2 EXPRESSION CONFERS ANDROGEN INDEPENDENCE IN ANDROGEN SENSITIVE PROSTATIC-CARCINOMA, International journal of oncology, 10(1), 1997, pp. 113-118
PHASE-II TRIAL OF 5-FLUOROURACIL, INTERFERON-ALPHA AND CONTINUOUS-INFUSION INTERLEUKIN-2 FOR PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
Authors: ELLERHORST JA SELLA A AMATO RJ TU SM MILLIKAN RE FINN LD BANKS M LOGOTHETIS CJ
Citation: Ja. Ellerhorst et al., PHASE-II TRIAL OF 5-FLUOROURACIL, INTERFERON-ALPHA AND CONTINUOUS-INFUSION INTERLEUKIN-2 FOR PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA, Cancer, 80(11), 1997, pp. 2128-2132
COMBINATION ADRIAMYCIN AND SURAMIN INDUCES APOPTOSIS IN BCL-2 EXPRESSING PROSTATE CARCINOMA-CELLS (VOL 93, PG 147, 1995)
Authors: TU SM MCCONNELL K MARIN MC CAMPBELL ML FERNANDEZ A VONESCHENBACH AC MCDONNELL TJ
Citation: Sm. Tu et al., COMBINATION ADRIAMYCIN AND SURAMIN INDUCES APOPTOSIS IN BCL-2 EXPRESSING PROSTATE CARCINOMA-CELLS (VOL 93, PG 147, 1995), Cancer letters, 99(2), 1996, pp. 247-247
ANALYSIS OF EPSILON(GAMMA-GLUTAMYL)LYSINE IN SERUM BY CAPILLARY ELECTROPHORESIS AND ITS USE AS AN APOPTOTIC MARKER IN CANCER-TREATMENT
Authors: SONG H TU SM HUIE R WONG SS
Citation: H. Song et al., ANALYSIS OF EPSILON(GAMMA-GLUTAMYL)LYSINE IN SERUM BY CAPILLARY ELECTROPHORESIS AND ITS USE AS AN APOPTOTIC MARKER IN CANCER-TREATMENT, Clinical chemistry, 42(6), 1996, pp. 657-657
ESCALATED MVAC WITH OR WITHOUT RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR THE INITIAL TREATMENT OF ADVANCED MALIGNANT UROTHELIAL TUMORS - RESULTS OF A RANDOMIZED TRIAL
Authors: LOGOTHETIS CJ FINN LD SMITH T KILBOURN RG ELLERHORST JA ZUKIWSKI AA SELLA A TU SM AMATO RJ
Citation: Cj. Logothetis et al., ESCALATED MVAC WITH OR WITHOUT RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR THE INITIAL TREATMENT OF ADVANCED MALIGNANT UROTHELIAL TUMORS - RESULTS OF A RANDOMIZED TRIAL, Journal of clinical oncology, 13(9), 1995, pp. 2272-2277
COMBINATION ADRIAMYCIN AND SURAMIN INDUCES APOPTOSIS IN BCL-2 EXPRESSING PROSTATE CARCINOMA-CELLS
Authors: TU SM MCCONNELL K MARIN MC CAMPBELL ML FERNANDEZ A VONESCHENBACH AC MCDONNELL TJ
Citation: Sm. Tu et al., COMBINATION ADRIAMYCIN AND SURAMIN INDUCES APOPTOSIS IN BCL-2 EXPRESSING PROSTATE CARCINOMA-CELLS, Cancer letters, 93(2), 1995, pp. 147-155
PACLITAXEL, CISPLATIN AND METHOTREXATE COMBINATION CHEMOTHERAPY IS ACTIVE IN THE TREATMENT OF REFRACTORY UROTHELIAL MALIGNANCIES
Authors: TU SM HOSSAN E AMATO R KILBOURN R LOGOTHETIS CJ
Citation: Sm. Tu et al., PACLITAXEL, CISPLATIN AND METHOTREXATE COMBINATION CHEMOTHERAPY IS ACTIVE IN THE TREATMENT OF REFRACTORY UROTHELIAL MALIGNANCIES, The Journal of urology, 154(5), 1995, pp. 1719-1722
THE BCL-2 ONCOGENE - APOPTOSIS AND NEOPLASIA
Authors: MCDONNELL TJ MARIN MC HSU B BRISBAY SM MCCONNELL K TU SM CAMPBELL ML RODRIGUEZVILLANUEVA J
Citation: Tj. Mcdonnell et al., THE BCL-2 ONCOGENE - APOPTOSIS AND NEOPLASIA, Radiation research, 136(3), 1993, pp. 307-312
Risultati: 1-15 |